Jinling Pharmaceutical Company Limited (SHE:000919)

China flag China · Delayed Price · Currency is CNY
7.77
+0.15 (1.97%)
Feb 4, 2026, 3:04 PM CST
19.72%
Market Cap4.74B +18.0%
Revenue (ttm)3.13B -13.5%
Net Income32.11M -62.4%
EPS0.05 -65.6%
Shares Out621.92M
PE Ratio146.99
Forward PEn/a
Dividend0.10 (1.32%)
Ex-Dividend DateJul 8, 2025
Volume11,287,350
Average Volume15,489,430
Open7.60
Previous Close7.62
Day's Range7.60 - 7.82
52-Week Range5.90 - 8.24
Beta0.45
RSI53.29
Earnings DateMar 31, 2026

About SHE:000919

Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products in China and internationally. The company offers Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, multiple arteriosclerosis, phlebitis, acute arterial embolism of the limbs, diabetic gangrene, venous thrombosis, and thrombophlebitis, etc., as well as cardiovascular and cerebrovascular diseases; Sulifei ferrous aluminate tablets for the prevention and treatment of... [Read more]

Sector Healthcare
Founded 1998
Employees 5,789
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000919
Full Company Profile

Financial Performance

In 2024, SHE:000919's revenue was 3.28 billion, an increase of 2.74% compared to the previous year's 3.19 billion. Earnings were 40.41 million, a decrease of -61.95%.

Financial Statements